Status:
UNKNOWN
Core Outcome Set for Pharmacist-led Interventions in CKD
Lead Sponsor:
University of Leicester
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Background Chronic kidney disease (CKD) is a progressive condition characterised by a gradual reduction in kidney function and structure over time. CKD is a risk factor for other morbidity, where it n...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- The stakeholders that will be invited to participate in this survey include: 1) self-defined pharmacists involved in the care of kidney patients and non-renal pharmacists; 2) self-defined researchers involved in CKD and pharmacy research; 3) self-defined nurses and physicians involved in CKD management; 4) self-defined people living with kidney disease; and 5) their carers and/or family members.
- It is likely that participants will not fit into distinct homogeneous groups; for example, researchers may also be registered pharmacists. Participants will answer questions relevant to their group. All participants over the age of 18 will be invited to take part in the survey
- Exclusion criteria:
- Any participants not self-defined as one of the above five groups.
Exclusion
Key Trial Info
Start Date :
July 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05987280
Start Date
July 20 2023
End Date
October 31 2024
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Wilkinson
Leicester, Leicestershire, United Kingdom, LE1 7RH